PROCEPT BioRobotics Corp (PRCT): Price and Financial Metrics
PRCT Price/Volume Stats
| Current price | $52.48 | 52-week high | $54.79 |
| Prev. close | $53.75 | 52-week low | $24.83 |
| Day low | $51.95 | Volume | 519,700 |
| Day high | $54.79 | Avg. volume | 499,018 |
| 50-day MA | $49.23 | Dividend yield | N/A |
| 200-day MA | $39.58 | Market Cap | 2.67B |
PRCT Stock Price Chart Interactive Chart >
PROCEPT BioRobotics Corp (PRCT) Company Bio
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
Latest PRCT News From Around the Web
Below are the latest news stories about PROCEPT BIOROBOTICS CORP that investors may wish to consider to help them evaluate PRCT as an investment opportunity.
Insider Sell Alert: EVP Alaleh Nouri Divests 15,000 Shares of PROCEPT BioRobotics CorpIn a notable insider transaction, Alaleh Nouri, the Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp, sold 15,000 shares of the company on December 15, 2023. |
Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT)In a notable insider transaction, Director Frederic Moll has parted with a significant number of shares in PROCEPT BioRobotics Corp (NASDAQ:PRCT). |
EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT)Kevin Waters, the Executive Vice President and Chief Financial Officer of PROCEPT BioRobotics Corp, has recently sold a significant number of shares in the company. |
PROCEPT BioRobotics Stock Scores Rising Relative StrengthPROCEPT BioRobotics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating |
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 32%PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) shares have had a really impressive month, gaining 32% after a shaky... |
PRCT Price Returns
| 1-mo | 11.64% |
| 3-mo | 13.89% |
| 6-mo | 101.15% |
| 1-year | 46.96% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 25.22% |
| 2023 | 0.89% |
| 2022 | 66.09% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...